XTX Topco’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $484K | Sell |
432,328
-26,980
| -6% | -$30.2K | 0.02% | 1123 |
|
|
2025
Q1 | $363K | Buy |
459,308
+209,508
| +84% | +$166K | 0.02% | 1262 |
|
|
2024
Q4 | $412K | Buy |
+249,800
| New | +$412K | 0.03% | 933 |
|
|
2024
Q3 | – | Sell |
-33,898
| Closed | -$111K | – | 2232 |
|
|
2024
Q2 | $111K | Buy |
33,898
+16,510
| +95% | +$54.2K | 0.01% | 1395 |
|
|
2024
Q1 | $128K | Buy |
+17,388
| New | +$128K | 0.02% | 1307 |
|
|
2023
Q4 | – | Sell |
-192,920
| Closed | -$409K | – | 1745 |
|
|
2023
Q3 | $409K | Buy |
192,920
+171,321
| +793% | +$363K | 0.07% | 525 |
|
|
2023
Q2 | $103K | Sell |
21,599
-6,591
| -23% | -$31.4K | 0.02% | 1159 |
|
|
2023
Q1 | $161K | Sell |
28,190
-76,000
| -73% | -$433K | 0.03% | 1010 |
|
|
2022
Q4 | $1.05M | Buy |
104,190
+83,670
| +408% | +$844K | 0.22% | 76 |
|
|
2022
Q3 | $460K | Buy |
+20,520
| New | +$460K | 0.11% | 275 |
|
|
2021
Q3 | – | Sell |
-5,039
| Closed | -$437K | – | 783 |
|
|
2021
Q2 | $437K | Buy |
+5,039
| New | +$437K | 0.15% | 224 |
|